Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Sep 6, 2017 at 8:50 AM EDT

How Insmed Is Capitalizing on Its Huge Late-Stage Success

Insmed has filed with the SEC for a secondary offering. This follows a surge in the share price following positive…

John Harrington | Sep 5, 2017 at 12:59 PM EDT

Deaths Linked to Drug Overdoses Surge in US

Drug overdose deaths for the 12 months ending January 2017 rose 21%, according to data from the CDC. Maryland led…

Chris Lange | Sep 5, 2017 at 11:40 AM EDT

FDA Crushes Cellectis With Clinical Hold

Cellectis shares tumbled early on Tuesday after the firm announced that a couple of its early-stage studies were put on…

Chris Lange | Sep 5, 2017 at 10:35 AM EDT

BioCryst Pharma Sees Brief Surge on Mid-Stage Trial Win

BioCryst Pharmaceuticals saw its shares make a handy gain on early Tuesday after it released the final results from its…

Chris Lange | Sep 5, 2017 at 9:50 AM EDT

Insmed More Than Doubles on Late-Stage Trial

Insmed saw its shares more than double early on Tuesday after the firm released late-stage results from its clinical study…

Chris Lange | Aug 31, 2017 at 10:20 AM EDT

FDA Crushes SteadyMed With Refusal to File Letter

SteadyMed shares plummeted after the firm had a setback from the FDA regarding its pulmonary arterial hypertension treatment.

Paul Ausick | Aug 30, 2017 at 2:05 PM EDT

1.5 Million Americans a Year Make Medication Errors

Taking more than a prescribed amount of medication leads to nearly 1.5 million calls annually to U.S. poison control centers.

Trey Thoelcke | Aug 30, 2017 at 1:05 PM EDT

ImmunoGen Riding High on Jazz Pharma Deal

ImmunoGen announced this week that it has decided to partner with Jazz Pharmaceuticals, and investors have pushed Immunogen shares to…

Chris Lange | Aug 30, 2017 at 10:10 AM EDT

Mazor Robotics Jumps After Medtronic Collaboration Update

Mazor Robotics saw its shares make a handy gain to kick off hump day after it was announced that the…

Chris Lange | Aug 30, 2017 at 8:40 AM EDT

Why Otonomy Shares Are Getting Absolutely Crushed

Otonomy saw its shares crater after the firm announced results for its Averts-1 late-stage trial of Otividex in patients with…

Chris Lange | Aug 29, 2017 at 10:10 AM EDT

ImmunoGen and Jazz Enter Into Global Collaboration

ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.

Chris Lange | Aug 29, 2017 at 9:50 AM EDT

Acorda Therapeutics Shares Crushed After Receipt of FDA Refusal Letter

Acorda Therapeutics saw its shares get crushed early on Tuesday after the firm received a Refusal to File letter from…

Chris Lange | Aug 28, 2017 at 10:00 AM EDT

Gilead Moves to Acquire Kite Pharma

Gilead Sciences shares have been in a holding pattern for a while. Analysts have said that the firm needs to…

Chris Lange | Aug 25, 2017 at 10:10 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The August 15 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Aug 25, 2017 at 9:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 157 158 159 160 161 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

How Insmed Is Capitalizing on Its Huge Late-Stage Success

Deaths Linked to Drug Overdoses Surge in US

FDA Crushes Cellectis With Clinical Hold

BioCryst Pharma Sees Brief Surge on Mid-Stage Trial Win

Insmed More Than Doubles on Late-Stage Trial

FDA Crushes SteadyMed With Refusal to File Letter

1.5 Million Americans a Year Make Medication Errors

ImmunoGen Riding High on Jazz Pharma Deal

Mazor Robotics Jumps After Medtronic Collaboration Update

Why Otonomy Shares Are Getting Absolutely Crushed

ImmunoGen and Jazz Enter Into Global Collaboration

Acorda Therapeutics Shares Crushed After Receipt of FDA Refusal Letter

Gilead Moves to Acquire Kite Pharma

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Run for Cover From Major Pharma

Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Live Nasdaq Composite: Markets Hold Breath on Mideast Deal, SpaceX IPO Launch

SpaceX Has 40% Upside from IPO per Wall Street Analyst. Here’s How

Here Are the Maximum Social Security Benefits at Ages 62, 67, and 70 in 2026 and How to Get Close

A $2.1 Million 401(k) at 75 Produces an $85,400 RMD That Pushes a Retiree Into the 24 Percent Bracket

Here Are the Maximum Social Security Benefits at Ages 62, 67, and 70 in 2026 and How to Get Close

A $2.1 Million 401(k) at 75 Produces an $85,400 RMD That Pushes a Retiree Into the 24 Percent Bracket

David Tepper Cuts Microsoft 82%, Billionaire Bill Ackman Buys $2 Billion of It. Who’s Winning?

SanDisk and Western Digital Jump 6% as Traders Battle Over the AI Storage Stock Melt-Up

Health and Healthcare Articles

All Health and Healthcare Articles

How Insmed Is Capitalizing on Its Huge Late-Stage Success

Deaths Linked to Drug Overdoses Surge in US

FDA Crushes Cellectis With Clinical Hold

BioCryst Pharma Sees Brief Surge on Mid-Stage Trial Win

Insmed More Than Doubles on Late-Stage Trial

FDA Crushes SteadyMed With Refusal to File Letter

1.5 Million Americans a Year Make Medication Errors

ImmunoGen Riding High on Jazz Pharma Deal

Mazor Robotics Jumps After Medtronic Collaboration Update

Why Otonomy Shares Are Getting Absolutely Crushed

ImmunoGen and Jazz Enter Into Global Collaboration

Acorda Therapeutics Shares Crushed After Receipt of FDA Refusal Letter

Gilead Moves to Acquire Kite Pharma

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Run for Cover From Major Pharma

Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Live Nasdaq Composite: Markets Hold Breath on Mideast Deal, SpaceX IPO Launch

SpaceX Has 40% Upside from IPO per Wall Street Analyst. Here’s How

Here Are the Maximum Social Security Benefits at Ages 62, 67, and 70 in 2026 and How to Get Close

A $2.1 Million 401(k) at 75 Produces an $85,400 RMD That Pushes a Retiree Into the 24 Percent Bracket

Featured Reads

Here Are the Maximum Social Security Benefits at Ages 62, 67, and 70 in 2026 and How to Get Close

A $2.1 Million 401(k) at 75 Produces an $85,400 RMD That Pushes a Retiree Into the 24 Percent Bracket